KIT and neoplasm: In animal model, compared to control mice with a single V558Δ Kit mutation, mice with a double V558Δ; V653A Kit mutation had increased tumor oncogenesis and associated KIT-dependent STAT activation, while cabozantinib was more effective in overcoming resistance than sunitinib[125].